Capricor Therapeutics Inc (CAPR)
6.20
+0.56
(+9.93%)
USD |
NASDAQ |
May 17, 16:00
6.22
+0.02
(+0.32%)
After-Hours: 20:00
Capricor Therapeutics Price to Book Value: 10.70 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 10.70 |
| May 16, 2024 | 9.732 |
| May 15, 2024 | 9.198 |
| May 14, 2024 | 8.973 |
| May 13, 2024 | 9.387 |
| May 10, 2024 | 9.085 |
| May 09, 2024 | 9.291 |
| May 08, 2024 | 9.205 |
| May 07, 2024 | 9.359 |
| May 06, 2024 | 9.479 |
| May 03, 2024 | 9.376 |
| May 02, 2024 | 8.982 |
| May 01, 2024 | 9.136 |
| April 30, 2024 | 9.034 |
| April 29, 2024 | 9.136 |
| April 26, 2024 | 9.274 |
| April 25, 2024 | 8.828 |
| April 24, 2024 | 8.639 |
| April 23, 2024 | 8.262 |
| April 22, 2024 | 8.468 |
| April 19, 2024 | 8.588 |
| April 18, 2024 | 8.656 |
| April 17, 2024 | 9.514 |
| April 16, 2024 | 10.16 |
| April 15, 2024 | 10.04 |
| Date | Value |
|---|---|
| April 12, 2024 | 10.71 |
| April 11, 2024 | 10.68 |
| April 10, 2024 | 10.80 |
| April 09, 2024 | 11.31 |
| April 08, 2024 | 11.28 |
| April 05, 2024 | 11.52 |
| April 04, 2024 | 11.48 |
| April 03, 2024 | 11.66 |
| April 02, 2024 | 11.81 |
| April 01, 2024 | 12.16 |
| March 31, 2024 | |
| March 28, 2024 | 9.464 |
| March 27, 2024 | 9.436 |
| March 26, 2024 | 8.795 |
| March 25, 2024 | 9.241 |
| March 22, 2024 | 8.893 |
| March 21, 2024 | 9.590 |
| March 20, 2024 | 9.548 |
| March 19, 2024 | 9.464 |
| March 18, 2024 | 9.422 |
| March 15, 2024 | 8.878 |
| March 14, 2024 | 8.572 |
| March 13, 2024 | 8.252 |
| March 12, 2024 | 8.197 |
| March 11, 2024 | 8.058 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7185
Minimum
Mar 10 2020
74.09
Maximum
Aug 28 2023
7.825
Average
3.854
Median
Price to Book Value Benchmarks
| Sarepta Therapeutics Inc | 12.92 |
| PTC Therapeutics Inc | -- |
| Solid Biosciences Inc | 1.630 |
| Inovio Pharmaceuticals Inc | 3.292 |
| Stereotaxis Inc | 11.91 |
Price to Book Value Related Metrics
| PS Ratio | 6.476 |
| Price | 6.20 |
| Earnings Yield | -13.39% |
| Market Cap | 197.23M |